A. Nilsson

Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain

A. Lazzarin, F. Chiodi, P. Cinque, 2001, AIDS (London).

First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies

G. Ullenhag, P. Norlén, J. Yachnin, 2019, International journal of cancer.

HIV-Producing T Cells in Cerebrospinal Fluid

R. Grant, R. Price, P. Bacchetti, 2004, Journal of acquired immune deficiency syndromes.

The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo

Adnan Deronic, P. Ellmark, A. Nilsson, 2021, Cancer Immunology, Immunotherapy.

HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.

C. Petropoulos, R. Price, T. Liegler, 2005, The Journal of infectious diseases.

Cerebrospinal fluid HIV infection and pleocytosis: Relation to systemic infection and antiretroviral treatment

C. Petropoulos, E. Paxinos, R. Price, 2005, BMC infectious diseases.

CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.

R. Price, M. Heyes, D. Verotta, 2004, Brain : a journal of neurology.